ADAMTS13 Activity and Autoantibodies Subclasses as Recurrency Risk Predictors In Acquired Thrombotic Thrombocytopenic Purpura.

被引：0
|
作者：
Bettoni, Giuseppe [1 ,2 ]
Lotta, Luca A. [1 ,2 ]
Consonni, Dario [3 ]
Motti, Dino F. A. [1 ,2 ]
Palla, Roberta [1 ,2 ]
Valsecchi, Carla [1 ,2 ]
Casoli, Gloria [1 ,2 ]
Rovati, Andrea [4 ]
Pizzuti, Michele [5 ]
Peyvandi, Flora
机构：
[1] Luigi Villa Fdn, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] Fdn IRCCS Ca Gr, Sci Direct, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Epidemiol, Dipartimento Med Prevent, Milan, Italy
[4] Osped Lodi, Dept Hematol, Lodi, Italy
[5] Osped San Carlo Borromeo Milano, Potenza, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1049 / 1049
页数：1
相关论文
共 50 条
  • [21] News in thrombotic thrombocytopenic purpura and ADAMTS13
    Joly, Berangere
    Beranger, Nicolas
    Benhamou, Ygal
    Coppo, Paul
    Veyradier, Agnes
    HEMATOLOGIE, 2021, 27 (04): : 188 - 199
  • [22] Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura
    Tsai, HM
    BLOOD, 2002, 100 (10) : 3839 - 3840
  • [23] The Reliability of ADAMTS13 Activity for Diagnosis of Thrombotic Thrombocytopenic Purpura
    Li, L.
    Ali, F.
    Ravikumar, N.
    Aslam, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Thrombotic thrombocytopenic purpura: The role of ADAMTS13
    Rogers, Heesun J.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2016, 83 (08) : 597 - 603
  • [25] Quantitative Analysis of the Domain-Specific Autoantibodies to ADAMTS13 in Patients with Acquired Thrombotic Thrombocytopenic Purpura
    Igari, Atsuko
    Moriki, Takanori
    Yamaguchi, Yusuke
    Nakagawa, Terumichi
    Wada, Hideo
    Matsumoto, Masanori
    Fujimura, Yoshihiro
    Soejima, Kenji
    Murata, Mitsuru
    BLOOD, 2011, 118 (21) : 528 - 528
  • [26] ADAMTS13 structure and anti-ADAMTS13 autoantibodies in immune mediated Thrombotic Thrombocytopenic Purpura
    Vanhoorelbeke, Karen
    HEMATOLOGIE, 2021, 27 (04): : 153 - 155
  • [27] Functional differences in autoantibodies against ADAMTS13 in patients with thrombotic thrombocytopenic purpura
    Shelat, Suresh
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 77 - 77
  • [28] Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura
    Page, Evaren E.
    Hovinga, Johanna A. Kremer
    Terrell, Deirdra R.
    Vesely, Sara K.
    George, James N.
    BLOOD, 2016, 128 (17) : 2175 - 2178
  • [29] Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
    Matsumoto, Masanori
    Bennett, Charles L.
    Isonishi, Ayami
    Qureshi, Zaina
    Hori, Yuji
    Hayakawa, Masaki
    Yoshida, Yoko
    Yagi, Hideo
    Fujimura, Yoshihiro
    PLOS ONE, 2012, 7 (03):
  • [30] Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura
    Tersteeg, Claudia
    Schiviz, Alexandra
    De Meyer, Simon F.
    Plaimauer, Barbara
    Scheiflinger, Friedrich
    Rottensteiner, Hanspeter
    Vanhoorelbeke, Karen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (11) : 2336 - 2342
12345